Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses

被引:0
|
作者
Sergei N. Shchelkunov
Rurik K. Salyaev
Sergei G. Pozdnyakov
Natalia I. Rekoslavskaya
Andrei E. Nesterov
Tatiana S. Ryzhova
Valentina M. Sumtsova
Natalia V. Pakova
Uliana O. Mishutina
Tatiana V. Kopytina
Rosemarie W. Hammond
机构
[1] State Research Center of Virology and Biotechnology “Vector”,Molecular Plant Pathology Laboratory
[2] Institute of Chemical Biology and Fundamental Medicine,undefined
[3] Siberian Branch of the Russian Academy of Sciences,undefined
[4] Siberian Institute of Plant Physiology and Biochemistry,undefined
[5] Siberian Branch of the Russian Academy of Sciences,undefined
[6] United States Department of Agriculture,undefined
[7] Agricultural Research Service,undefined
来源
Biotechnology Letters | 2006年 / 28卷
关键词
Hepatitis B virus; Human immunodeficiency virus; Oral plant-based vaccine; Transgenic tomato;
D O I
暂无
中图分类号
学科分类号
摘要
A synthetic chimeric gene, TBI-HBS, encoding the immunogenic ENV and GAG epitopes of human immunodeficiency virus (HIV-1) and the surface protein antigen (HBsAg) of hepatitis B virus (HBV), was expressed in tomato plants. Tomato fruits containing the TBI-HBS antigen were fed to experimental mice and, on days 14 and 28 post-feeding, high levels of HIV- and HBV-specific antibodies were present in the serum and feces of the test animals. Intraperitoneal injection of a DNA vaccine directing synthesis of the same TBI-HBsAg antigen boosted the antibody response to HIV in the blood serum; however, it had no effect on the high level of antibodies produced to HBV.
引用
收藏
页码:959 / 967
页数:8
相关论文
共 50 条
  • [21] Engineering a Novel Bivalent Oral Vaccine against Enteric Fever
    Soulier, Annelise
    Prevosto, Claudia
    Chol, Mary
    Deban, Livija
    Cranenburgh, Rocky M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06)
  • [22] Safety and immunogenicity of a bivalent Haemophilus influenzae type b hepatitis B vaccine in healthy infants
    West, DJ
    Hesley, TM
    Jonas, LC
    Feeley, LK
    Bird, SR
    Burke, P
    Sadoff, JC
    Bromberg, K
    Chartrand, S
    Johnson, D
    Keyserling, H
    Petersen, K
    Rabalais, G
    Reisinger, K
    Rothstein, E
    Seto, D
    Sullivan, B
    Watson, B
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (06) : 593 - 599
  • [23] Efficacy of a food plant-based oral cholera toxin B subunit vaccine
    Takeshi Arakawa
    Daniel K.X. Chong
    William H. R. Langridge
    Nature Biotechnology, 1998, 16 : 292 - 297
  • [24] Efficacy of a food plant-based oral cholera toxin B subunit vaccine
    Arakawa, T
    Chong, DKX
    Langridge, WHR
    NATURE BIOTECHNOLOGY, 1998, 16 (03) : 292 - 297
  • [25] Toward the Development of a Plant-Based Vaccine Against Reovirus
    Wu, Hongzhuan
    Scissum-Gunn, Karyn
    Singh, Narendra K.
    Giambrone, Joseph J.
    AVIAN DISEASES, 2009, 53 (03) : 376 - 381
  • [26] Evaluation of the oral immunogenicity of M cell-targeted tetravalent EDIII antigen for development of plant-based edible vaccine against dengue infection
    Kim, Byeong-Young
    Kim, Mi-Young
    PLANT CELL TISSUE AND ORGAN CULTURE, 2019, 137 (01) : 1 - 10
  • [27] Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses
    Sahay, Bikash
    Aranyos, Alek M.
    Mishra, Meerambika
    McAvoy, Andrew C.
    Martin, Marcus M.
    Pu, Riuyu
    Shiomitsu, Sayaka
    Shiomitsu, Keijiro
    Dark, Michael J.
    Sanou, Missa P.
    Roff, Shannon R.
    Rathore, Mobeen H.
    Yamamoto, Janet K.
    VIRUSES-BASEL, 2019, 11 (02):
  • [28] Evaluation of the oral immunogenicity of M cell-targeted tetravalent EDIII antigen for development of plant-based edible vaccine against dengue infection
    Byeong-Young Kim
    Mi-Young Kim
    Plant Cell, Tissue and Organ Culture (PCTOC), 2019, 137 : 1 - 10
  • [29] Novel nanocarrier for oral Hepatitis B vaccine
    Dinda, Amit K.
    Bhat, Madhusudan
    Srivastava, Sandeep
    Kottarath, Sarat K.
    Prashant, Chandravilas K.
    VACCINE, 2016, 34 (27) : 3076 - 3081
  • [30] WAYS TO AN OPTIMAL VACCINE AGAINST HEPATITIS-B VIRUSES
    GERLICH, WH
    HEERMANN, KH
    THOMSSEN, R
    IMMUNITAT UND INFEKTION, 1988, 16 (05): : 167 - 174